Inducible de novo expression of neoantigens in tumor cells and mice
Author(s)
Damo, Martina; Fitzgerald, Brittany; Lu, Yisi; Nader, Mursal; William, Ivana; Cheung, Julie F.; Connolly, Kelli A.; Foster, Gena G.; Akama-Garren, Elliot; Lee, Da-Yae; Chang, Greg P.; Gocheva, Vasilena; Schmidt, Leah M.; Boileve, Alice; Wilson, Josephine H.; Cui, Can; Monroy, Isabel; Gokare, Prashanth; Cabeceiras, Peter; Jacks, Tyler; Joshi, Nikhil S.; ... Show more Show less
DownloadAccepted version (3.687Mb)
Open Access Policy
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Inducible expression of neoantigens in mice would enable the study of endogenous antigen-specific naïve T cell responses in disease and infection, but has been difficult to generate because leaky antigen expression in the thymus results in central T cell tolerance. Here we develop inversion-induced joined neoantigen (NINJA), using RNA splicing, DNA recombination and three levels of regulation to prevent leakiness and allow tight control over neoantigen expression. We apply NINJA to create tumor cell lines with inducible neoantigen expression, which could be used to study antitumor immunity. We also show that the genetic regulation in NINJA mice bypasses central and peripheral tolerance mechanisms and allows for robust endogenous CD8 and CD4 T cell responses on neoantigen induction in peripheral tissues. NINJA will enable studies of how T cells respond to defined neoantigens in the context of peripheral tolerance, transplantation, autoimmune diseases and cancer.
Date issued
2020-07Department
Koch Institute for Integrative Cancer Research at MIT; Massachusetts Institute of Technology. Department of Biology; Howard Hughes Medical InstituteJournal
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
ISSN
1087-0156
1546-1696